As we reflect on the Autumn Budget, the UK’s Office for Budget Responsibility (OBR) is back in the spotlight. Could its influence go beyond fiscal rules and help unlock investment in healthcare – driving better outcomes and UK economic growth? This article explores this question with insights from leading experts. Healthy Returns: the role of the Office for Budget Responsibility in assessing healthcare spending which delivers economic growth from Maria Lucia Tereno, Country Managing Director and Head of Human Pharma, Boehringer Ingelheim.
Read More via the link HERE
